Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Protalix Biotherapeutics
(NY:
PLX
)
0.9101
+0.0101 (+1.12%)
Official Closing Price
Updated: 8:00 PM EDT, Aug 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Protalix Biotherapeutics
< Previous
1
2
3
Next >
Mid-Day Market Update: Crude Oil Rises 1%; iRhythm Technologies Shares Plunge
June 02, 2021
`Midway through trading Wednesday, the Dow traded up 0.33% to 34,689.77 while the NASDAQ rose 0.16% to 13,758.43. The S&P also rose, gaining 0.30% to 4,214.55. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Protalix Shares Hits 52-Week Low After Adverse Event Reported In Fabry Disease Trial With PRX-102
June 02, 2021
Protalix BioTherapeutics Inc (NYSE: PLX) and Chiesi Farmaceutici S.p.A. have provided an update on the clinical development of pegunigalsidase alfa (PRX...
Via
Benzinga
40 Stocks Moving In Wednesday's Mid-Day Session
June 02, 2021
Gainers BriaCell Therapeutics Corp. (NASDAQ: BCTX) shares jumped 147.3% to $7.86 after the company provided an update on the overall survival (OS) data on its previously...
Via
Benzinga
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
May 01, 2021
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...
Via
Benzinga
Exposures
Product Safety
Stocks That Hit 52-Week Lows On Wednesday
June 02, 2021
Before 10 a.m. ET on Wednesday, 8 companies hit new 52-week lows. Highlights: Dun & Bradstreet Hldgs (NYSE:DNB) was the biggest company by market cap to set a new 52-...
Via
Benzinga
Looking Into Protalix BioTherapeutics's Return On Capital Employed
May 20, 2021
Protalix BioTherapeutics (AMEX:PLX) reported Q1 sales of $11.32 million. Earnings fell to a loss of $3.71 million, resulting in a 230.5% decrease from last quarter. In Q4,...
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
May 14, 2021
Before 10 a.m. ET on Friday, 24 stocks hit new 52-week lows. Noteworthy Mentions: The largest company in terms of market cap to set a new 52-week low was Canadian...
Via
Benzinga
Earnings Scheduled For May 14, 2021
May 14, 2021
Companies Reporting Before The Bell • Sogou (NYSE:SOGO) is projected to report earnings for its first quarter. • Sohu.com (NASDAQ:SOHU) is estimated to report...
Via
Benzinga
The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts
May 14, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 13) Alexion Pharmaceuticals, Inc...
Via
Benzinga
Exposures
Product Safety
Earnings Preview for Protalix BioTherapeutics
May 13, 2021
On Friday, May 14, Protalix BioTherapeutics (AMEX:PLX) will release its latest earnings report. Here is Benzinga's outlook for the company. Net Income, Earnings, And Earnings Per...
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
May 11, 2021
Before 10 a.m. ET Tuesday, 173 stocks hit new 52-week lows. Intriguing Points: The largest company by market cap to set a new 52-week low was Snowflake (NYSE:SNOW...
Via
Benzinga
22 Stocks Moving in Monday's Pre-Market Session
May 03, 2021
Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) rose 58.3% to $78.90 in pre-market trading. Nicholas Jason Singer disclosed a 9.13% passive stake in Brooklyn...
Via
Benzinga
Attention Biotech Investors: Mark Your Calendar For May PDUFA Dates
May 01, 2021
Following a mixed month in April, the Food and Drug Administration sets out to review another slate of drugs in May. ACADIA Pharmaceuticals Inc.'s (NASDAQ: ACAD) Nuplazid...
Via
Benzinga
Mid-Afternoon Market Update: Dow Drops 90 Points; Fed Leaves Rates Unchanged
April 28, 2021
Toward the end of trading Wednesday, the Dow traded down 0.26% to 33,894.93 while the NASDAQ fell 0.01% to 14,090.09. However, the S&P gained 0.13% to 4,192.05. The U.S. has...
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
60 Biggest Movers From Yesterday
April 29, 2021
Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) shares gained 75.6% to settle at $43.73 on Wednesday. The company recently said it paid $1 million towards acquisition of...
Via
Benzinga
Why Protalix BioTherapeutics Stock Is Plunging Today
April 28, 2021
Investors did not like the company's latest regulatory update.
Via
The Motley Fool
Mid-Day Market Update: Crude Oil Rises 2%; Protalix BioTherapeutics Shares Plunge
April 28, 2021
Midway through trading Wednesday, the Dow traded down 0.33% to 33,874.02 while the NASDAQ fell 0.07% to 14,079.66. The S&P also rose, gaining 0.15% to 4,193.17. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
41 Stocks Moving In Wednesday's Mid-Day Session
April 28, 2021
Gainers Aurora Mobile Limited (NASDAQ: JG) shares climbed 21.3% to $4.27 after Oppenheimer initiated coverage on the stock with an Outperform rating and a price target of $6 per...
Via
Benzinga
Mid-Morning Market Update: Markets Mixed; Alphabet Tops Q1 Expectations
April 28, 2021
Following the market opening Wednesday, the Dow traded down 0.43% to 33,839.68 while the NASDAQ rose 0.10% to 14,104.41. The S&P also rose, gaining 0.19% to 4,194.68. The U.S...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping
April 28, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc...
Via
Benzinga
Exposures
Product Safety
25 Stocks Moving in Wednesday's Pre-Market Session
April 28, 2021
Gainers RiceBran Technologies (NASDAQ: RIBT) rose 16.1% to $1.37 in pre-market trading after jumping around 27% on Tuesday. The company is scheduled to report Q1 earnings today....
Via
Benzinga
Protalix Stock Falls After FDA Slaps CRL For PRX-102 Application In Fabry Disease
April 28, 2021
Protalix BioTherapeutics Inc (NYSE: PLX) and Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici, have received a Complete Response...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout
April 27, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 26) 10x Genomics, Inc. (NASDAQ...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Understanding Protalix BioTherapeutics's Unusual Options Activity
April 19, 2021
Protalix BioTherapeutics (AMEX:PLX) shares experienced unusual options activity on Monday. The stock price moved up to $6.25 following the option alert. Sentiment: BEARISH Option...
Via
Benzinga
The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx
April 24, 2021
Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:...
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.